This study explored patients' and healthcare professionals' views and knowledge of pharmacogenetic testing and associated future service development. Patients and healthcare professionals discussed ...

With the rapid advances in the field of genetics and a growing understanding of the human brain and body, the past few decades have seen a rise in precision (or personalized) medicine. We know that ...

Most antidepressants are metabolized through the cytochrome P (CYP) 450 pathway; therefore, most drug metabolism genes on pharmacogenetic testing panels are related to CYP450 oxidase enzyme subunits.

Differences in people’s genes can affect how they respond to medications, including how well a drug works and the chances of side effects. About 1 in 10 prescriptions given to patients outside the ...